Langham Logistics has opened a 320,000-square-foot pharmaceutical cold-chain warehouse in Plainfield, in a spot the company says sits adjacent to Indianapolis International Airport. The operation is described as a GMP-compliant facility with more than 46,000 refrigerated pallet positions and a dedicated 2°C–8°C cooler for biologics and vaccines, sharply expanding Central Indiana’s life-sciences logistics footprint.
The company first laid out the project in a May 4 press release on PR.com, detailing how the new site fits into its broader growth strategy. The Indianapolis Business Journal later highlighted the opening for local readers.
“Our clients are navigating an increasingly complex supply chain environment where quality, speed, and scalability are critical,” Langham CEO Cathy Langham said in the company announcement on PR.com. According to the release, the Plainfield facility supports serialization, re-palletization and case-picking workflows for biologics, vaccines and advanced therapies, and is configured to streamline onboarding for new pharmaceutical customers.
Why Plainfield?
The warehouse sits in Plainfield’s well-established logistics corridor along Airtech Parkway, a stretch planners and developers have been grooming for large-bay warehouses and airport-linked distribution. Town planning documents and traffic studies for the Airtech Parkway corridor outline road improvements and signal capacity aimed at supporting that kind of large-scale logistics build-out. Materials from the Town of Plainfield show the corridor’s role in recent industrial growth.
Jobs and Hiring
To run the life-sciences operation, Langham is staffing up in the area. Job boards list roles ranging from quality managers to inventory control associates and supervisors tied directly to the Plainfield site. Listings on Indeed and Lensa show multiple openings that reflect GMP-regulated, temperature-controlled warehouse work.
Part of a National Cold-Chain Push
Langham’s move lines up with a broader national trend. Investors and third-party logistics providers across the country are racing to expand pharma-grade cold storage to keep up with rising volumes of biologics and specialty therapies. Market research from Mordor Intelligence forecasts stronger growth in cold-chain warehousing than in traditional ambient storage as biologics and vaccines drive demand.
Regulatory and Quality Controls
Because the Plainfield site handles pharmaceuticals, it operates under strict GMP and warehousing procedures that include validated temperature control, quarantine protocols and traceability. Federal rules such as 21 CFR 211.142 require written warehousing procedures and set a baseline for audits and client qualification, with operators expected to meet those standards, according to the eCFR.
Langham has said the Plainfield opening is part of a broader growth push for its life-sciences business, and company reporting notes additional expansion plans in other U.S. markets, including North Carolina. Local officials say the new center further cements Central Indiana’s role as a distribution hub for temperature-sensitive medicines at a time when demand for cold-chain capacity keeps climbing.
